Inhibition of active autophagy induces apoptosis and increases chemosensitivity in cholangiocarcinoma (Q33925154)

30 July 2017

Inhibition of active autophagy induces apoptosis and increases chemosensitivity in cholangiocarcinoma (English)

1 reference

30 July 2017

0 references

0 references

1 reference

Yu-Jie Hou

1

1 reference

30 July 2017

Li-Wei Dong

2

1 reference

30 July 2017

Ye-Xiong Tan

3

1 reference

30 July 2017

Guang-Zhen Yang

4

1 reference

30 July 2017

Yu-Fei Pan

5

1 reference

30 July 2017

Zhong Li

6

1 reference

30 July 2017

Liang Tang

7

1 reference

30 July 2017

Min Wang

8

1 reference

30 July 2017

Qing Wang

9

1 reference

30 July 2017

Hong-Yang Wang

10

1 reference

30 July 2017

6 June 2011

1 reference

30 July 2017

Laboratory Investigation

1 reference

30 July 2017

91

1 reference

30 July 2017

8

1 reference

30 July 2017

1146-1157

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.2011.97

30 July 2017

0 references

cites work

Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

A proposed staging system for intrahepatic cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Prognostic molecular markers in cholangiocarcinoma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Diagnosis and treatment of cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Development by self-digestion: molecular mechanisms and biological functions of autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Autophagy in the Pathogenesis of Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Role of autophagy in suppression of inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Autophagy as a regulated pathway of cellular degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

The E-cadherin repressor slug and progression of human extrahepatic hilar cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Autophagy delays apoptotic death in breast cancer cells following DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Use of adenovirus-delivered siRNA to target oncoprotein p28GANK in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Signal regulatory protein alpha negatively regulates both TLR3 and cytoplasmic pathways in type I interferon induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Suppression of cyclin D1 by hypoxia-inducible factor-1 via direct mechanism inhibits the proliferation and 5-fluorouracil-induced apoptosis of A549 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

ARK5 suppresses the cell death induced by nutrient starvation and death receptors via inhibition of caspase 8 activation, but not by chemotherapeutic agents or UV irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Hepatitis B virus X protein sensitizes cells to starvation-induced autophagy via up-regulation of beclin 1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

RNA interference targeting slug increases cholangiocarcinoma cell sensitivity to cisplatin via upregulating PUMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Autophagy inhibition enhances anthocyanin-induced apoptosis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Role of autophagy in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Cellular autophagy: surrender, avoidance and subversion by microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Autophagy: basic principles and relevance to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

The role of autophagy in cancer development and response to therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1alpha expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Decreased expression of autophagy-related proteins in malignant epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Mechanisms of resistance to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Cisplatin: mode of cytotoxic action and molecular basis of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Molecular mechanisms of resistance and toxicity associated with platinating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

inferred from DOI database lookup

7 January 2021

based on heuristic

Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

inferred from DOI database lookup

7 January 2021

based on heuristic

Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.97

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LABINVEST.2011.97

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference